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spectroscopyAbstract Introduction: Primary CNS lymphoma is difﬁcult to diagnose with conventional imag-
ing modalities. Magnetic resonance proton spectroscopy, dynamic susceptibility contrast DSC
perfusion and diffusion weighted images have been recently investigated as a problem-solving
tool for evaluation of primary CNS lymphoma with favorable results.
Aim of the work: To assess the value of advanced neuro-imaging (MR diffusion, perfusion and pro-
ton spectroscopy) in diagnosis of primary CNS lymphoma.
Patients and methods: Five adult patients with suspected primary CNS lymphoma (as suggested by
clinical or conventional imaging techniques) were prospectively studied by magnetic resonance pro-
ton spectroscopy, dynamic susceptibility contrast DSC perfusion and diffusion weighted images
aiming to conﬁrm the suspected diagnosis. The examinations were done on 1.5T machines using dif-
fusion weighted, dynamic susceptibility contrast perfusion and chemical shift CSI imaging
sequences.
Results: Regarding DWI, all patients show low ADC values ranging from 0.61 to 0.67 · 103 mm2/s
with a mean ADC value of 0.63 ± 0.025(SD) · 103 mm2/s, regarding the DSC perfusion. The
max rCBV ratios are ranging from 0.23 to 1.52 with a mean ratio of 1.14 ± 0.54(SD). Regarding
304 M.H. Kayed et al.the MRI spectroscopy Cho/Cr ratios are ranging from 1.9 to 63 with a mean ratio of 19.16 ± 26
(SD), Cho/NAA ratios are ranging from 3.7 to 50 with a mean ratio of 14.8 ± 19.8, NAA/Cr ratios
are ranging from 0.09 to 1.6 with a mean ratio of 0.72 ± 0.59, NAA/Cho ratios are ranging from
0.02 to 0.3 with a mean ratio of 0.19 ± 0.1 Lactate peak was found in three cases. Lipid peak was
found in two cases. Myo inositol peak was found in one case.
Conclusions: Restricted diffusion, relative hypo perfusion, increased Cho/Cr, Cho/NAA, decreased
NAA/Cho, NAA/Cr and presence of lactate or lipid peaks are consistent imaging ﬁnding in CNS
lymphoma.
ª 2013 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Primary central nervous system lymphoma (PCNSL) is deﬁned
as isolated intra axial brain and spinal cord involvement with
absence of primary tumor foci at any other sites of the body,
primary lymphomatous inﬁltration of the CNS occurs in
healthy populations, AIDS, post organ transplantation
patients and also in patients receiving chemotherapy. It is con-
sidered as a rare disease in all categories with increased inci-
dence in the latter groups.1 The role of advanced neuro
imaging is not limited only to provide anatomic details but
also helps for proper diagnosis of the disease, the value of
the advanced magnetic resonance imaging techniques, such
as MR diffusion, DSC perfusion imaging and MR proton
spectroscopy, in the diagnosis of adult CNS lymphoma will
be discussed in this study.2
The ratio of PCNSL among malignant tumors of the brain
and spinal cord is ranging from 1% to 6%and of all extra-nodal
non-Hodgkin’s lymphomas are ranging from 3% to 5%.3,4 The
incidence is 0.5:1/000,000/year so it is considered as a rare
occurrence.5 The clinical and imaging features of PCNSL differ
according to the immunological status of the patients,6 this
study is only limited to the immunocompetent patients.
The most predominant pathological type of PCNS lym-
phoma in the immunocompetent patients is the Non-Hodg-
kin’s B-cell variant.7 B-cell type of primary CNS lymphoma
is more frequent in male patients and occurs mainly among
elder age groups of 50–60 years.7 The most common symptoms
at the initial presentations of the disease include alteration and
deterioration of mental status, sub-acute hemiparesis, head-
ache, nausea, cerebellar manifestations including ataxia, cra-
nial nerve palsies, and visual disturbances.7,8
Other tools used for diagnosis of the PCNLS include Cyto-
logical CSF analysis, which only diagnoses about less than half
of patients with primary CNS lymphoma.8 Stereotactic biopsy
for pathological diagnosis of cerebral lymphoma is the most
accurate method however specimens may be insufﬁcient for
diagnosis yet still both techniques are invasive methods and
have multiple complications related to the intervention.8
The common initial radiological presentation of lympho-
matous lesions is a large sized intra axial mass with peri focal
edema and mass effect.9 The use of steroids medication as
attempts to reduce the peri focal edema of the lesion and relief
pressure effects on the brain tissue may compromise and inter-
fere with the trails of stereotactic brain and spinal needle biop-
sies or CSF analysis.10 Diagnosis of PCNSL by image based
interpretation is crucial to avoid resection which is not improv-
ing the prognosis and survival rate of the patients as well as toavoid false negative results which may be seen in the follow up
images.11
Primary CNS lymphoma may arise from any region of the
brain however; the most common site of origin is the deep
hemispheric periventricular white matter. It can arise also from
the Corpus callosum, orbits, cranial nerves and cerebellum.12
Most of the lymphomas appear in conventional MR imag-
ing techniques as hypo or iso intense to gray matter on T1-WI,
variable signal intensities yet predominantly hypo intense on
T2-WI and show avid enhancement after contrast administra-
tion.13 The MR imaging ﬁndings of PCNS lymphomas are
extremely variable and intermingled with MR imaging ﬁndings
of other intracranial tumors regarding the distribution, signal
intensity pattern, peri focal edema, mass effect and enhance-
ment pattern such as high grade gliomas, deposits or meningi-
omas. Therefore, the proper diagnosis of CNS lymphoma is
difﬁcult on conventional MRI.14
Diffusion MR imaging, diffusion detects the water mole-
cules’ random motion as they diffuse through the extra-cellular
space; tumor diffusion is considered as a marker for tumor cel-
lularity.15 CNS lymphomas are highly cellular tumors; diffu-
sion restriction is one of their main features, making them
appear hyper-intense on DWI and hypo-intense on ADC
maps.16
Perfusion MR imaging, perfusion refers to oxygen and
nutrients’ delivery to the cells via capillaries in the biologic tis-
sue (tumors); with calculation of cerebral blood ﬂow, cerebral
blood volume, mean transit time, and time to peak, cerebral
lymphomas show relatively low rCBV values compared with
similar appearing tumors.17
MR spectroscopy monitors biochemical changes in tumors
depending upon the chemical shift phenomena using proton
(hydrogen) nuclei. In PCNSL proton MR spectroscopy shows
high Cho/Cr ratios and elevated lipid, lactate and choline
peaks, reduced NAA peaks are also detected.18,19
2. Aim of the work
To assess the value of advanced neuro-imaging (MR diffusion,




Between December 2011 and December 2012, patients who
presented to the Neuro Surgery Unit in Alexandria Main
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were referred to the Radio Diagnosis Department for imaging
assessment. Five adult patients (3 males and 2 females) age
ranged from 27 to 82 years (median age 57 years) presented
with one of the following clinical presentations focal neurolog-
ical deﬁcit, alteration of mental status, hemiparesis, increased
intracranial pressure, and seizures.
The presence of speciﬁc altered attenuation or signal pat-
tern as iso dense to hyper dense lesions on CT scan and iso
to hypo intense lesions on T2-weighted MRI. Speciﬁc location,
central, hemispheric or periventricular cerebral white matter,
Frontal lobe, basal ganglia, brain stem or cerebellum also
superﬁcial location adjacent to the meninges. Enhancement
pattern as homogeneous or ring-like enhancement is driving
attention to further advanced neuro imaging evaluation.
3.2. Imaging techniques and analysis
MR imaging was performed using Siemens Avanto 1.5 MR
system with a standard head coil. Conventional MRI study
was done with conventional T2 [fast spin echo (FSE), ﬂuid
attenuated inversion recovery (FLAIR)], T1 and susceptibility
Weighted SWI sequences, with T1 post intravenous adminis-
tration of paramagnetic contrast material (gadobutrol,
0.1 mmol/kg, Magnevist, Schering, Germany).
3.3. Diffusion analysis
The DWI study was performed with a T2-weighted, echo-pla-
nar spin-echo sequence EPI (TR 3400, TE 100, matrix
192 · 192, slice thickness 5 mm, gap 30%) with a duration of
120 s and B= 0, B= 500, and B= 1,000. Isotropic maps
of the ADC maps were calculated, and the lowest ADC was
measured in the lesion core.
3.4. Perfusion analysis
The standard PWI protocol was performed with a T2-weighted
echo planar spin-echo sequence EPI (TR 1.480, TE 30, matrix
128 · 128, slice thickness 5 mm, gap 0, number of scans 50,
IPAT2 Grappa 128 epi factor) with duration of 81 s. Nineteen
images per second were acquired during the passage of a bolus
of 0.1 mmol/kg of gadobutrol, injected with an automatic
injector at a ﬂow velocity of 5 ml/s through an 18- to 20-gauge
needle cannula, followed by irrigation of 20 ml saline solution.
Post processing was performed with a dedicated software
package (Syngo neuro perfusion evaluation). Color maps of
the cerebral blood volume were obtained, and the maximum
regional cerebral blood volume (rCBV) was calculated by plac-
ing the region of interest ROI in the solid areas showing the
highest color intensity. Data were then compared with those
of the normal-appearing contralateral or ipsilateral whiteTable 1 Patient demographic data and conventional MRI image ﬁ
Case no. Sex Age (years) T2 signal pa
1 M 27 Hypo-intens
2 M 39 Hypo-intens
3 F 65 Iso-intense
4 M 82 Hyper-inten
5 F 57 Hypo-intensmatter and expressed as a ratio of rCBV [ratio = rCBV
(lesion)/rCBV (normal appearing white matter)].
3.5. Spectroscopy analysis
MR spectroscopy multi-voxel 2D CSI was performed with an
echo time of intermediate TE (135) (TR 1500, FOV 160 mm,
acquisition time 7 min 34 s) to evaluate the levels of choline
(Cho), creatine (Cr), N-acetyl aspartate (NAA), lactate and
lipids. Also we acquired data at short TE (30) to evaluate myo-
inositol (MI) using a Point Resolved Spectroscopy (PRESS)
Sequences. The size and position of the region of interest
ROI were determined by examination of the MR images in
all three dimensions (Sagittal, Coronal and Transverse planes),
the aim is to include the largest volume of the tumor, peri-
tumoral area as well as the normal appearing brain within
the region of interest as much as possible and to exclude bone,
air, and subcutaneous fat (the regions with large variations in
magnetic susceptibility). Appropriate automatic shimming
achieved by using 4–8- HZ line width, 1-kHz spectral width,
and Water suppression using the CHESS technique (chemical
shift selective saturation) were done and post processing per-
formed with automated software package (Syngo spectroscopy
evaluation).
3.6. Pathological analysis
The diagnoses were conﬁrmed by pathology. Routinely pro-
cessed parafﬁn-embedded tissues were cut and stained with
the conventional H&E stain and reticulin stain. Sections on
coated slides were submitted to immunohistochemistry for
CD20, CD3, pancytokeratin and S-100. Both the primary anti-
body and the detection kit were purchased from Lab Vision
Corporation (Neo Markers, USA). Immunohistochemical
staining was performed using an avidin–biotinylated immun-
operoxidase methodology.
4. Results
Patient’s demographic and conventional MRI imaging data are
demonstrated in Table 1. AdvancedMRI imaging data are dem-
onstrated in Table 2. Conventional MRI showed central loca-
tion of the lesion for four patients and peripheral cortical and
sub cortical location with central extension for one patient
(Table 1; case 3) (Fig. 1D), multiple lesions are noted in four
patients (Fig. 2), single lesion is noted in one patient (Table 1;
case 2) (Fig. 3), low signal intensity to gray matter within the
lesions in T2 weighted images found in three patients, T2 iso
intense signals found in one patient (Table 1; case 3), high T2 sig-
nal intensity found in one patient (Table 1; case 4), intense
enhancement noted in four patients (Fig. 3A), and moderate
rim enhancement noted in one patient (Table 1; case 5).ndings.
ttern Location Number Enhancement
e Central Multiple Intense
e Central Single Intense
Peripheral Multiple Intense
se Central Multiple Intense
e Central Multiple Moderate
Figure 1 A 65 year old female with well inﬁltrative right fronto-parietal lesion. (A) rCBV color perfusion map shows right parietal
cortical area of relative hyper perfusion. (B) Color intermediate echo spectroscopic map with right frontal para falcine foci of high Cho/
NAA ratios (red colored). (C) Diffusion weighted image shows foci of low ADC values with profound restriction. (D) T2 W image shows
iso intense to gray matter inﬁltrative right fronto-parietal lesion.
Table 2 Patient demographic data and advanced MRI neuro-image ﬁndings.
Case no. Age (years) Sex ADC (·103 mm2/s) rCBV Perfusion Cho/Cr Cho/NAA NAA/Cr NAA/Cho Lac Lipid MI
1 27 M 0.61 1.12 Decreased 24 50 0.09 0.02 Yes Yes No
2 39 M 0.62 0.23 Deceased 63 10 1.6 0.3 No No No
3 65 F 0.67 1.38 Increased 1.9 3.7 0.5 0.26 Yes Yes No
4 82 M 0.62 1.48 Increased 4.3 4.29 1 0.23 No No No
5 57 F 0.65 1.52 Increased 2.61 6.37 0.41 0.16 Yes No Yes
rCBV, relative cerebral blood volume; ADC, apparent diffusion coefﬁcient; NAA, N acetyl aspartate; Cr, creatine; Cho, choline; MI, myo
inositol; Lac, lactate.
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weighted images and ADC values. All patients show low
ADC values (Figs. 1C, 2A, 3B) ranging from 0.61 to
0.67 · 103 mm2/s with a mean ADC value of
0.63 ± 0.025(SD) · 103 mm2/s (Table 2; case 1 and 3). For
the central lesions the range of ADC values is from 0.61 to
0.65 · 103 mm2/s with a mean ADC value of 0.625 ±0.017 · 103 mm2/s, Slightly higher ADC value is noted for
the peripheral lesion 0.67 · 103 mm2/s (Table 2; case 3).
Regarding the perfusion weighted images the maximum rel-
ative CBV ratio in all patients is summarized in Table 2. The
rCBV ratios are ranging from 0.23 to 1.52 with a mean. rCVB
ratio of 1.14 ± 0.54(SD) (Table 2; case 2 and 5) (Fig. 1A),
perfusion is decreased with max. rCVB below 1.2 in two cases
Figure 2 A 27 year old male with multiple lesions involving both cerebral hemispheres. (A) Diffusion weighted image shows large left
parieto- occipital lesion with low ADC values and profound restriction. (B) rCBV color perfusion map for the same lesion shows area of
relative hypo perfusion. (C) Color intermediate echo spectroscopic map shows foci of high Cho/Cr ratios (red colored). (D) Intermediate
echo spectroscopy curve shows very high Cho levels and very low Cr &NAA levels with lactate peak (inverted peak at 1.33 ppm).
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(case 3, 4 and 5) (Figs. 2B, 3C).
Regarding the MRI spectroscopy all the metabolic ratios
are summarized in Table 2. Cho/Cr ratios are ﬂuctuating,
ranging from 1.9 up to 63 with a mean ratio of 19.16 ± 26
(SD), showing very high values in case (1 and 2) 24 and 63
respectively (Fig. 2C). Cho/NAA ratios are also ranging from
3.7 to 50 with a mean ratio of 14.8 ± 19.8 showing very high
values in case (1 and 2) 50 and 10, respectively (Figs. 1B, 3D)
.NAA/Cr ratios ranged from 0.09 to 1.6 with a mean ratio of
0.72 ± 0.59, NAA/Cho ratios ranged from 0.02 to 0.3 with
mean ratio 0.19 ± 0.1, lactate peak is found in three
cases (case 1, 3 and 5) (Fig. 2D). Lipid peak was found in
two cases (case 1 and 3). Myo inositol peak is found in one
case (case 5).5. Discussion
Primary central nervous system lymphoma PCNSL is a rare
aggressive neoplasm with increased incidence in the lastdecade among healthy populations and AIDS patients
because of the newly developed medication that increases
the survival rate of these patients, also among post organ
transplant patients on immuno-suppressors and cancer
patients on chemotherapy.1 The diagnosis of CNS lymphoma
is difﬁcult by conventional MRI imaging. However, the
proper diagnosis of CNS lymphoma and accurate differentia-
tion from other intracranial mass lesions such as high
grade gliomas, deposits, or meningiomas are important,
because the management and prognosis are variable for these
different types of tumors.20
Diffusion pattern of primary CNS lymphoma is low in
most of the lesions reﬂecting high cellularity, they appear
hyper intense on DWI along the different B values and hypo
intense on ADC maps.21 PCNSL lesions show evident diffu-
sion restriction and have lower ADC values than similar
appearing high-grade gliomas and deposits,22 other lesions
appearing with high signal intensity in DWI are acute ische-
mic stroke, pyogenic brain abscesses, intermediate grade gli-
omas, so they should be considered when diagnosing
lymphoma.22
Figure 3 A 39 year old male with left deep parietal lesion. (A) Contrast enhanced T1 images show intensely enhancing left deep parietal
lesion with necrotic core. (B) Diffusion weighted image shows thick peripheral rim of low ADC values and profound restriction. (C) rCBV
color perfusion map for the same lesion shows area of manifest hypo perfusion. (D) Color intermediate echo spectroscopic map shows
area of high Cho/NAA ratios (red colored).
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ing max. relative cerebral blood volume (rCBV) ratio are cru-
cial for diagnosis of PCNS lymphomas, max. relative CBV
measured in tumor tissue and it shows relatively lower values
in lymphomas than in other brain malignancies. This impor-
tant ﬁnding may differentiate high grade gliomas and deposits
from lymphomas.23
PCNSL spectroscopic analysis shows variable spectral pre-
sentations with the presence of multiple zones of transitions
between normal brain and tumor tissues. MR spectral pattern
in PCNSL shows decreased NAA/Cho, NAA/Cr and
increased Cho/Cr, Cho/NAA ratios; in few patients Cho was
the only observable metabolite, others show decreased NAA
level. Several patients had lactate, lipid, or both within the
evaluated region of interest.18Our results revealed that the rate of diffusion of CNS
lymphomas, as represented by ADC value numbers, was
signiﬁcantly low, ADC values ranging from 0.61 to
0.67 · 103 mm2/s with a mean ADC value of
0.63 ± 0.025 · 103 mm2/s. In a study by Guo et al.,24 the
mean ADC of CNS lymphoma was 0.87 ± 0.27 · 10–3
mm2/s, whereas the mean ADC of high grade astrocytoma
was 1.21 ± 0.35 · 10–3 mm2/s. Results of other studies25
on this issue have revealed higher ADCs, up to
1.37 ± 0.52 · 10–3 mm2/s. These ﬁndings were matching with
our results of diffusion weighted MR pattern and ADC map
analyses. Lymphomas were hyper intense to gray matter on
diffusion-weighted images and relatively isointense to hypoin-
tense on ADC maps, these ﬁndings are attributed to low
diffusivity.24
The added value of advanced neuro-imaging (MR diffusion, perfusion and proton spectroscopy) in diagnosis 309In this study, the results showed that the maximum rCBV
ratios were less than 1.2 in two patients and more than 1.2
in other three patients. These results (mean value:
1.14 ± 0.54) are similar to the previous reports (mean values:
1.10–2.48).25 These ﬁndings are different from other tumors
such as high grade gliomas (mean values: 4.03–7.32) or metas-
tasis (mean values: 4.68–5.27) or meningiomas (mean value:
8.02–10.58) with high max. rCBV ratios.26 Sugahara et al.
reported that cerebral lymphomas had a tendency to have
lower rCBV values in 1999.28 Hakyemez et al.27 reported that
the rCBV ratios of lymphomas were lower than those of high
grade gliomas in 2006. Avid enhancement without higher
rCBV ratios in lymphoma is attributed to destruction of the
blood brain barrier without neovascularization in contrast to
the avid contrast enhancement with neovascularization in high
grade gliomas.26
In this study MR spectra with PCNSL consisted of
increased Cho/Cr with mean ratio 19.16 ± 26, Cho/NAA with
mean ratio 14.8 ± 19.8 and decreased NAA/Cho with mean
ratio 0.19 ± 0.1 and NAA/Cr with mean ratio 0.72 ± 0.59,
high lipid and lactate peaks, unexpected ﬁnding with the pres-
ence of myo inositol peak in one patient; These ratios are
matching with PCNSL patients reported in literatures,29 ele-
vated lipid, Cho and decreased NAA ratios may help in differ-
entiating between high grade glioma and lymphoma.18,29 The
increase in Cho likely results from high mitotic activity,
increased cell turnover rate and the dense cellularity of lym-
phomas.29 The lipid signals related to fatty acyl molecules were
released during membrane breakdown.30 The spectroscopic
patterns seen in PCNSL are similar to high grade glioma.
However, increasing ratios of Cho/Cr, Cho/NAA or decreas-
ing NAA/Cho and NAA/Cr in PCNSL are related to tumor
progression and possibly increased aggression rather than
increased tumor grade.31
6. Conclusion
Advanced MR imaging techniques add more characteristic
ﬁndings for the diagnosis of CNS lymphoma that may help
in the differentiation of CNS lymphomas from other CNS
malignancies. Diffusion restriction, relative hypo perfusion,
increased Cho/Cr, Cho/NAA, decreased NAA/Cho, NAA/Cr
as well as the presence of lactate and lipid peaks, these ﬁndings
are consistent imaging ﬁndings in CNS lymphoma.Conﬂict of interest
None declared.
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